tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Balance Sheet

Compare
535 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q3 2025 were $1.42B, an increase of 2.70% from the previous quarter. SUPN total liabilities were $370.09M for the fiscal quarter, a 16.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 1.37B$ 1.28B$ 1.70B$ 1.69B$ 1.50B
Total Liabilities
$ 332.34M$ 356.16M$ 816.30M$ 873.30M$ 759.24M
Total Equity Gross Minority
$ 1.04B$ 921.52M$ 886.20M$ 815.85M$ 744.86M
Other Metrics
Currency in USD

Supernus Pharmaceuticals Debt to Assets